Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center
Columbia University
AIDS Malignancy Consortium
Weill Medical College of Cornell University
UNC Lineberger Comprehensive Cancer Center
AIDS Malignancy Consortium
Duke University